Skip to content

Clinical trials

Endometrial Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: New Zealand Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20171
20182
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCAGY/ GINECO GROUP1
BeiGene1
Canadian Cancer Trials Group1
Checkpoint Therapeutics, Inc.1
Eikon Therapeutics1
Eisai Inc.1
Mario Negri Institute for Pharmacological Research1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Queensland Centre for Gynaecological Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms10
Neoplasms4
Carcinoma2
Neoplasm Metastasis2
Adenocarcinoma1
Breast Neoplasms1
Carcinoma, Merkel Cell1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Carcinoma, Small Cell1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.